Registry-listed formulations

DEXCHLORPHENIRAMINE MALEATE · chembl:CHEMBL1200927

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

5 source entries across 4 studies. This list may not include all unresolved or historical entries.

  • POLARAMINE 5 mg/1 ml, solution injectableRegistry product

    Molecular identity unconfirmed

    Formulation reported by source: SOLUTION FOR INJECTION

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source
  • POLARAMINE 5 mg/1 ml, solution injectableRegistry product

    Molecular identity unconfirmed

    Formulation reported by source: SOLUTION FOR INJECTION

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source
  • Polaramine 5 mg/ml solución inyectableRegistry product

    Molecular identity unconfirmed

    Formulation reported by source: SOLUTION FOR INJECTION

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source
  • Polaramine 2 mg comprimidosRegistry product

    Molecular identity unconfirmed

    Formulation reported by source: TABLET

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source
  • DEXCHLORPHENIRAMINE MALEATERegistry product

    Linked study entry; product equivalence not established

    Formulation reported by source: SYRUP

    View study and source

Success Metrics

Active Trials
1(100%)

Phase Distribution

Phase 2
1
100%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (100.0%)

Trials by Status

active_not_recruiting1100%

Recent Activity

Clinical Trials (1)

Drug Details

Intervention Type
Type not reported
Molecule Type
Small molecule
Total Trials
1

External References

Names & Codes

Research Codes

NSC-759156